In summary, beyond our conclusive findings about protection against HR+ breast cancers, our observations about non-breast cancer outcomes suggest that future studies be performed to quantitate the non-breast cancer protective interactions between preeclampsia and IGF1R rs2016347 T allele inheritance in populations statistically powered to assess ovarian, colorectal and uterine cancer development. The gene discussed is IGF1R; the disease is preeclampsia.